| Literature DB >> 28670915 |
Antoine M Saab1, Roberto Gambari2, Gianni Sacchetti2, Alessandra Guerrini2, Ilaria Lampronti2, Massimo Tacchini2, Antoine El Samrani3, Samir Medawar4, Hassane Makhlouf3, Mona Tannoury3, Jihad Abboud4, Mona Diab-Assaf1, Anake Kijjoa5, Rosa Tundis6, Jawad Aoun1, Thomas Efferth7.
Abstract
Natural products frequently exert pharmacological activities. The present review gives an overview of the ethnobotany, phytochemistry and pharmacology of the Cedrus genus, e.g. cytotoxic, spasmolytic immunomodulatory, antiallergic, anti-inflammatory and analgesic activities. Cancer patients frequently seek remedies from traditional medicinal plants that are believed to exert less side effects than conventional therapy with synthetic drugs. A long-lasting goal of anti-cancer and anti-microbial therapy research is to find compounds with reduced side effects compared to currently approved drugs. In this respect, Cedrus species might be of interest. The essential oil isolated from Cedrus libani leaves may bear potential for drug development due to its high concentrations of germacrene D and β-caryophyllene. The essential oils from Cedrus species also show bioactivity against bacteria and viruses. More preclinical analyses (e.g. in vivo experiments) as well as clinical trials are required to evaluate the potential of essential oils from Cedrus species for drug development.Entities:
Keywords: Antiproliferative activity; Cedrus atlantica; Cedrus deodara; Cedrus libani; Pinaceae; essential oils; leukaemia cells
Mesh:
Substances:
Year: 2017 PMID: 28670915 DOI: 10.1080/14786419.2017.1346648
Source DB: PubMed Journal: Nat Prod Res ISSN: 1478-6419 Impact factor: 2.861